Key facts
- This page summarizes Richard E. Lowenthal's Form 4 filing for ARS Pharmaceuticals, Inc. (SPRY).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 May 2024, 18:57.
Richard E. Lowenthal - 07 May 2024 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)
- Issuer symbol
- SPRY
- Report date
- 07 May 2024
- Net transaction value
- -$934,365
- Form type
- 4
- Accepted by SEC
- 09 May 2024, 18:57:04 UTC
- Previous filing
- 24 Apr 2024
- Next filing
- 16 May 2024
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Kathleen Scott, Attorney-in-Fact
Source evidence
5 source fields
Reporting owner
1 detail
Key filing fact
Richard E. Lowenthal filed Form 4 for ARS Pharmaceuticals, Inc. (SPRY) on 09 May 2024.
Change
- Previous filing in this sequence was filed on 24 Apr 2024.
- Current net transaction value: -$934,365.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPRY
transaction
Common Stock
Sale
- Transaction value
- $467,135
- Shares
- -50,000
- Change %
- -3%
- Price
- $9.34
- Shares after
- 1,596,494
- Date
- 07 May 2024
- Ownership
- By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
- Footnotes
- F1, F2, F3
SPRY
transaction
Common Stock
Sale
- Transaction value
- $467,230
- Shares
- -50,000
- Change %
- -2.7%
- Price
- $9.34
- Shares after
- 1,798,499
- Date
- 07 May 2024
- Ownership
- By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
- Footnotes
- F1, F4, F5
SPRY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,315,313
- Date
- 07 May 2024
- Ownership
- Direct
SPRY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,647,447
- Date
- 07 May 2024
- Ownership
- By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
- Footnotes
- F6
SPRY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,407,847
- Date
- 07 May 2024
- Ownership
- By Spouse
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.
Footnote F2
The weighted average sale price for the transaction reported was $9.3427, and the range of prices were between $9.14 and $9.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Footnote F3
The Reporting Person is trustee of the trust.
Footnote F4
The weighted average sale price for the transaction reported was $9.3446, and the range of prices were between $9.14 and $9.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Footnote F5
The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.
Footnote F6
The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.